Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
08/29/2000 | US6110460 Methods of using morphogen analogs |
08/29/2000 | US6110426 Methods for fabricating microarrays of biological samples |
08/29/2000 | CA2189031C Microbiological medium |
08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
08/25/2000 | CA2300692A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
08/24/2000 | WO2000049557A2 Computer-implemented nucleic acid isolation method and apparatus |
08/24/2000 | WO2000049416A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
08/24/2000 | WO2000049413A2 Rapid assay for arthropod-borne disease vectors and pathogens |
08/24/2000 | WO2000049405A2 Detection of pathogens, especially spirochetes, from body fluids |
08/24/2000 | WO2000049182A2 Analytical methods and materials for nucleic acid detection |
08/24/2000 | WO2000049181A1 Multiplex method for nucleic acid detection |
08/24/2000 | WO2000049180A1 Detection of nucleic acid hybrids |
08/24/2000 | WO2000049179A1 Methods for determining the presence of nucleic acid target sequences and applications thereof |
08/24/2000 | WO2000049178A2 Polynucleotide sequencing method |
08/24/2000 | WO2000049177A2 HIGH DENSITY SAMPLING OF DIFFERENTIALLY EXPRESSED PROKARYOTIC mRNA |
08/24/2000 | WO2000049176A1 Method and apparatus for nucleic acid strand separation |
08/24/2000 | WO2000049175A1 Diagnosis and treatment of prostate cancer |
08/24/2000 | WO2000049174A1 Method for determining the susceptibility of a niddm patient toward sulfonylurea therapy |
08/24/2000 | WO2000049173A2 Method and sample support system for separating and processing substances in situ |
08/24/2000 | WO2000049172A1 Determination of nuclease activity |
08/24/2000 | WO2000049171A1 Detection of cells using the luciferase/luciferin reaction |
08/24/2000 | WO2000049169A1 Diagnostic polymorphisms |
08/24/2000 | WO2000049163A1 Production of heterologous polypeptides from freshwater caulobacter |
08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
08/24/2000 | WO2000049161A1 REPORTER CONSTRUCTS TO MONITOR cAMP LEVELS |
08/24/2000 | WO2000049160A1 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders |
08/24/2000 | WO2000049153A1 Fucosyl transferase gene |
08/24/2000 | WO2000049150A1 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
08/24/2000 | WO2000049143A1 Method for analyzing gene expression frequency |
08/24/2000 | WO2000049141A2 A method for production and delivery of a protein in vivo |
08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
08/24/2000 | WO2000049031A2 Method for isolating nucleic acids |
08/24/2000 | WO2000048991A1 Salicylamide-lanthanide complexes for use as luminescent markers |
08/24/2000 | WO2000048990A1 Phthalamide-lanthanide complexes for use as luminescent markers |
08/24/2000 | WO2000048627A1 Inhibitors of separin, method for identifying them and uses |
08/24/2000 | WO2000048606A1 Compositions and methods for use in targeting vascular destruction |
08/24/2000 | WO2000034652A8 Methods of identifying point mutations in a genome |
08/24/2000 | WO2000029550A3 Low oxygen culturing of central nervous system progenitor cells |
08/24/2000 | WO2000025138A3 Methods of diagnosing or prognosing alzheimer's disease |
08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
08/24/2000 | WO2000022167A9 Method for determining transcription factor activity and its technical uses |
08/24/2000 | WO2000022160A9 Methods for assessing complement activation |
08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
08/24/2000 | WO2000020605A9 Sulfotransferase sequence variants |
08/24/2000 | WO2000020554A9 Microfabricated cell injector |
08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
08/24/2000 | WO2000018963A8 Methods for breeding for and screening of soybean plants with enhanced yields, and soybean plants with enhanced yields |
08/24/2000 | WO2000018962A9 Methods and compositions for amplifying detectable signals in specific binding assays |
08/24/2000 | WO2000017399A8 High resolution genome scanning |
08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
08/24/2000 | WO2000014281A3 Assays using crosslinkable immobilized nucleic acids |
08/24/2000 | WO2000013017A9 Method and device for producing and/or analyzing biochemical reaction supporting materials |
08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
08/24/2000 | WO2000009754A3 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
08/24/2000 | WO2000005390A3 Controlling starch synthesis |
08/24/2000 | WO2000005382A3 A nucleic acid encoding a geranyl-geranyl pyrophosphate synthetase (ggpps) and polymorphic markers associated with said nucleic acid |
08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
08/24/2000 | WO1999042828A3 Treating cancer |
08/24/2000 | WO1998046792A3 Genetic marker based pig selection |
08/24/2000 | DE19907023A1 Isolation of nucleic acids, useful for e.g. genetic diagnosis by amplification, by adsorption onto polymeric beads at neutral or acidic pH then release at basic pH |
08/24/2000 | DE19854196A1 Verfahren zur Modifikation und Identifikation funktioneller Stellen in Proteinen A method of modifying and identification of functional sites in proteins |
08/24/2000 | DE10006491A1 Selective enrichment or separation of biological material e.g. organisms, organs tissues, organelles, and membranes, in liquid media, comprises using stationary and mobile phases |
08/24/2000 | CA2371880A1 Method and sample support system for separating and processing substances in situ |
08/24/2000 | CA2371825A1 Computer-implemented nucleic acid isolation method and apparatus |
08/24/2000 | CA2368461A1 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
08/24/2000 | CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes |
08/24/2000 | CA2362987A1 Receptor assay |
08/24/2000 | CA2362979A1 Method for isolating nucleic acids |
08/24/2000 | CA2362943A1 Pyk2 binding proteins |
08/24/2000 | CA2362300A1 Human lipid-associated proteins |
08/24/2000 | CA2359645A1 High density sampling of differentially expressed prokaryotic mrna |
08/24/2000 | CA2359613A1 Methods for determining the presence of nucleic acid target sequences and applications thereof |
08/24/2000 | CA2357011A1 Multiplex method for nucleic acid detection |
08/24/2000 | CA2356927A1 Detection of nucleic acid hybrids |
08/24/2000 | CA2356122A1 Detection of cells using the luciferase/luciferin reaction |
08/24/2000 | CA2296782A1 Downstream genes of tumor suppressor wt1 |
08/24/2000 | CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex |
08/23/2000 | EP1030178A1 Improved immunohistochemical staining method and reagents therefor |
08/23/2000 | EP1029929A1 Method for determining the susceptibility of a NIDDM patient toward sulfonylurea therapy |
08/23/2000 | EP1029928A2 Method for determining cholestrol and sensor applicable to the same |
08/23/2000 | EP1029917A1 The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
08/23/2000 | EP1029915A2 Expression of G protein coupled receptors in yeast |
08/23/2000 | EP1029914A2 Growth hormone-regulated growth marker gene |
08/23/2000 | EP1029547A1 Pharmaceutically active compounds and method for identifying same |
08/23/2000 | EP1029241A2 Process for determining cell vitality and efficiency in parallel after a gene transfer into eukaryotic cells and dual test system |
08/23/2000 | EP1029240A1 Calibration of measured physical parameters |
08/23/2000 | EP1029235A1 Measuring device comprising a sampling cell and used for detecting small amounts of samples in liquids |
08/23/2000 | EP1029229A1 Biosensor |
08/23/2000 | EP1029084A2 Specific and sensitive method for detecting nucleic acids |
08/23/2000 | EP1029083A2 Specific and sensitive nucleic acid detection method |
08/23/2000 | EP1029082A2 DETECTION AND TYPING OF THE $i(iceA) GENE OF $i(HELICOBACTER PYLORI) |
08/23/2000 | EP1029081A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
08/23/2000 | EP1029080A1 Human blood bacterium |
08/23/2000 | EP1029079A2 Diagnostics and therapeutics for chronic obstructive airway disease |
08/23/2000 | EP1029078A2 Analyte detection process using dual labeled probes |
08/23/2000 | EP1029077A2 A specific and sensitive nulceic acid detection method |
08/23/2000 | EP1029076A1 Screening for novel compounds which regulate biological interactions |